Skip to main content
Top
Published in: American Journal of Clinical Dermatology 6/2016

01-12-2016 | Review Article

Drug-Induced Tactile Hallucinations Beyond Recreational Drugs

Authors: Mio Nakamura, John Koo

Published in: American Journal of Clinical Dermatology | Issue 6/2016

Login to get access

Abstract

In monosymptomatic hypochondriacal psychosis (MHP), such as delusional infestation (DI), the patient has a fixed, false, encapsulated belief associated with tactile hallucinations (TH), most commonly formication, which is defined as cutaneous sensations of crawling, stinging, biting, etc., without evidence of infestation. Drug-induced TH should be considered in patients with suspected MHP. Although recreational drugs such as cocaine, amphetamines, and narcotics are well known to induce TH, many busy practicing dermatologists may not be familiar with other types of medications that can induce TH. A literature search for peer-reviewed articles was conducted in the PubMed, PsychInfo, Cochrane, and Embase databases. For each article, the medication(s) that induced TH was identified in a systematic way. The most commonly reported group of medications to induce TH was anti-Parkisonian agents, followed by antidepressants, prescription stimulants, antihypertensives (propranolol), and antiepileptics. In many cases, other types of hallucinations, such as visual and auditory, were present. Patients also commonly presented with psychiatric comorbidities. Although the conclusions that can be derived from this literature review are limited, it appears that certain medications that alter neurotransmitters, especially dopamine and, less convincingly, norepinephrine and serotonin, can be associated with TH. Drug-induced TH should also be considered in patients presenting with multiple types of hallucinations and patients with existing psychiatric comorbidity. Drug-induced TH, especially with an underlying psychiatric diagnosis that is separate from MHP, may be a more manageable disease entity compared with bona fide MHP.
Literature
1.
go back to reference Vulink NC. Delusional infestation: state of the art. Acta Derm Venereol. 2016;96:58–63.PubMed Vulink NC. Delusional infestation: state of the art. Acta Derm Venereol. 2016;96:58–63.PubMed
3.
go back to reference American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington (VA): American Psychiatric Association; 2013.CrossRef American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington (VA): American Psychiatric Association; 2013.CrossRef
4.
go back to reference Koo J. Psychodermatology: a practical manual for clinicians. Curr Probl Dermatol. 1995;7:199–234.CrossRef Koo J. Psychodermatology: a practical manual for clinicians. Curr Probl Dermatol. 1995;7:199–234.CrossRef
7.
go back to reference Goetz CG, Vogel C, Tanner CM, Stebbins GT. Early dopaminergic drug-induced hallucinations in Parkinsonian patients. Neurology. 1998;51:811–4.CrossRefPubMed Goetz CG, Vogel C, Tanner CM, Stebbins GT. Early dopaminergic drug-induced hallucinations in Parkinsonian patients. Neurology. 1998;51:811–4.CrossRefPubMed
8.
go back to reference Moskovitz C, Moses H, Klawans HL. Levodopa-induced psychosis: a kindling phenomenon. Am J Psych. 1978;135:669–75.CrossRef Moskovitz C, Moses H, Klawans HL. Levodopa-induced psychosis: a kindling phenomenon. Am J Psych. 1978;135:669–75.CrossRef
9.
go back to reference Kataoka H, Sawa N, Sugie K, Ueno S. Dopamine agonists trigger tactile hallucinations in patients with Pakinson’s Disease? J Neurol Sci. 2014;347:361–3.CrossRefPubMed Kataoka H, Sawa N, Sugie K, Ueno S. Dopamine agonists trigger tactile hallucinations in patients with Pakinson’s Disease? J Neurol Sci. 2014;347:361–3.CrossRefPubMed
10.
go back to reference Flann S, Shotbolt J, Kessel B, et al. Three cases of delusional parasitosis caused by dopamine agonists. Clin Exp Dermatol. 2010;35(7):740–2.CrossRefPubMed Flann S, Shotbolt J, Kessel B, et al. Three cases of delusional parasitosis caused by dopamine agonists. Clin Exp Dermatol. 2010;35(7):740–2.CrossRefPubMed
11.
go back to reference Swick B, Walling H. Drug-induced delusions of parasitosis during treatment of Parkinson’s disease. J Am Acad Dermatol. 2005;53:1086–7.CrossRefPubMed Swick B, Walling H. Drug-induced delusions of parasitosis during treatment of Parkinson’s disease. J Am Acad Dermatol. 2005;53:1086–7.CrossRefPubMed
12.
go back to reference Fénelon G, Thobois S, Bonnet AM, Broussolle E, Tison F. Tactile hallucinations in Parkinson’s disease. J Neurol. 2002;249:1699–703.CrossRefPubMed Fénelon G, Thobois S, Bonnet AM, Broussolle E, Tison F. Tactile hallucinations in Parkinson’s disease. J Neurol. 2002;249:1699–703.CrossRefPubMed
13.
go back to reference Jiménez-Jiménez FJ, Ortí-Pareja M, Gasalla T, Tallón-Barranco A, Cabrera-Valdivia F, Fernández-Lliria A. Cenesthetic hallucinations in a patient with Parkinson’s disease. J Neurol Neurosur Psychiatry. 1997;63:120.CrossRef Jiménez-Jiménez FJ, Ortí-Pareja M, Gasalla T, Tallón-Barranco A, Cabrera-Valdivia F, Fernández-Lliria A. Cenesthetic hallucinations in a patient with Parkinson’s disease. J Neurol Neurosur Psychiatry. 1997;63:120.CrossRef
15.
16.
go back to reference Arora GS, Arora HK, Sidhu J, Najjar F. Tactile hallucinations with fluoxetine and methylphenidate. J Child Adolesc Psychopharmacol. 2014;6:360–1.CrossRef Arora GS, Arora HK, Sidhu J, Najjar F. Tactile hallucinations with fluoxetine and methylphenidate. J Child Adolesc Psychopharmacol. 2014;6:360–1.CrossRef
17.
go back to reference Coskun M, Zoroglu S. Tactile and visual hallucinations in a child with methylphenidate and fluoxetine combination. J Clin Psychopharmacol. 2008;28:723–5.CrossRefPubMed Coskun M, Zoroglu S. Tactile and visual hallucinations in a child with methylphenidate and fluoxetine combination. J Clin Psychopharmacol. 2008;28:723–5.CrossRefPubMed
18.
go back to reference Charuvastra A, Yaeger D. Tactile hallucinations associated with therapeutic doses of bupropion in 2 patients. J Clin Psychiatry. 2006;67(11):1820–1.CrossRefPubMed Charuvastra A, Yaeger D. Tactile hallucinations associated with therapeutic doses of bupropion in 2 patients. J Clin Psychiatry. 2006;67(11):1820–1.CrossRefPubMed
19.
go back to reference Liskin B, Roose SP, Walsh BT, Jackson WK. Acute psychosis following phenelzine discontinuation. J Clin Psychopharm. 1985;5(1):46–7.CrossRef Liskin B, Roose SP, Walsh BT, Jackson WK. Acute psychosis following phenelzine discontinuation. J Clin Psychopharm. 1985;5(1):46–7.CrossRef
20.
go back to reference Peabody CA. Trazodone withdrawal and formication. J Clin Psychiatry. 1987;48(9):385.PubMed Peabody CA. Trazodone withdrawal and formication. J Clin Psychiatry. 1987;48(9):385.PubMed
21.
go back to reference Hvizdos AJ, Bennett JA, Wells BG, Rappaport KB, Mendel SA. Anticholinergic psychosis in a patient receiving usual doses of haloperidol, desipramine, and benztropine. Clin Pharm. 1983;2(2):174–8.PubMed Hvizdos AJ, Bennett JA, Wells BG, Rappaport KB, Mendel SA. Anticholinergic psychosis in a patient receiving usual doses of haloperidol, desipramine, and benztropine. Clin Pharm. 1983;2(2):174–8.PubMed
22.
go back to reference Liebowitz MR, Nuetzel EJ, Bowser AE, Klein DF. Phenelzine and delusions of parasitosis: a case report. Am J Psychiatry. 1978;135:1422–33.CrossRef Liebowitz MR, Nuetzel EJ, Bowser AE, Klein DF. Phenelzine and delusions of parasitosis: a case report. Am J Psychiatry. 1978;135:1422–33.CrossRef
23.
go back to reference Stanciu CN, Penders TM, Oxentine HN. Delusional infestation following misuse of prescription stimulants. Psychosomatics. 2015;56(2):210–2.CrossRefPubMed Stanciu CN, Penders TM, Oxentine HN. Delusional infestation following misuse of prescription stimulants. Psychosomatics. 2015;56(2):210–2.CrossRefPubMed
24.
go back to reference Buscarino M, Saal J, Young JL. Delusional parasitosis in a female treated with mixed amphetamine salts: a case report and literature review. Case Rep Psychiatry. 2012;2012:624235.PubMedPubMedCentral Buscarino M, Saal J, Young JL. Delusional parasitosis in a female treated with mixed amphetamine salts: a case report and literature review. Case Rep Psychiatry. 2012;2012:624235.PubMedPubMedCentral
25.
go back to reference Rashid J, Mitelman S. Methylphenidate and somatic hallucinations. J Am Acad Child Psychiatry. 2007;46(8):945–6.CrossRef Rashid J, Mitelman S. Methylphenidate and somatic hallucinations. J Am Acad Child Psychiatry. 2007;46(8):945–6.CrossRef
26.
go back to reference Young JG. Methylphenidate-induced hallucinosis: case histories and possible mechanisms of action. J Dev Behav Pediatr. 1981;2:35–8.CrossRefPubMed Young JG. Methylphenidate-induced hallucinosis: case histories and possible mechanisms of action. J Dev Behav Pediatr. 1981;2:35–8.CrossRefPubMed
27.
go back to reference Horn JR, Rylander ML, Hicks HM. Propranolol-induced hallucinosis. Clin Pharm. 1982;1(5):464–8.PubMed Horn JR, Rylander ML, Hicks HM. Propranolol-induced hallucinosis. Clin Pharm. 1982;1(5):464–8.PubMed
28.
go back to reference Kurland ML. Organic brain syndrome with propranolol. N Engl J Med. 1979;300(7):366.PubMed Kurland ML. Organic brain syndrome with propranolol. N Engl J Med. 1979;300(7):366.PubMed
30.
go back to reference Moreira CA, Soares AR, Maia G. Psychiatric antiepileptics side effects: a case report. Eur Psychiatry. 2016;33(Suppl):S348. Moreira CA, Soares AR, Maia G. Psychiatric antiepileptics side effects: a case report. Eur Psychiatry. 2016;33(Suppl):S348.
31.
go back to reference Oh HK, Tebrewal P, Dhillon R. Lamotrigine-induced tactile hallucination. J Clin Psychiatry. 2014;75(11):e1330.CrossRefPubMed Oh HK, Tebrewal P, Dhillon R. Lamotrigine-induced tactile hallucination. J Clin Psychiatry. 2014;75(11):e1330.CrossRefPubMed
32.
go back to reference Shrestha PV, Syed A, Marwaha R. Lacosamide-induced tactile hallucinations in a patient with complex partial seizures. J Neuropsychiatry Clin Neurosci. 2014;26(3):E8–9.CrossRefPubMed Shrestha PV, Syed A, Marwaha R. Lacosamide-induced tactile hallucinations in a patient with complex partial seizures. J Neuropsychiatry Clin Neurosci. 2014;26(3):E8–9.CrossRefPubMed
33.
go back to reference Mukonzo JK, Okwera A, Nakasujja N, et al. Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort study. BMC Infect Dis. 2013;4(13):261.CrossRef Mukonzo JK, Okwera A, Nakasujja N, et al. Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort study. BMC Infect Dis. 2013;4(13):261.CrossRef
35.
go back to reference Siemianowski LA, Rosenheck JP, Whitman CB. Nalbuphine-induced psychosis treated with naloxone. Am J Health Syst Pharm. 2014;71:717–21.CrossRefPubMed Siemianowski LA, Rosenheck JP, Whitman CB. Nalbuphine-induced psychosis treated with naloxone. Am J Health Syst Pharm. 2014;71:717–21.CrossRefPubMed
36.
go back to reference Selvaraj V, Skaf M, Sharma A, Farooq U, Frederick P. Eszopiclone-induced psychosis. Innov Clin Neurosci. 2012;9(10):11.PubMedPubMedCentral Selvaraj V, Skaf M, Sharma A, Farooq U, Frederick P. Eszopiclone-induced psychosis. Innov Clin Neurosci. 2012;9(10):11.PubMedPubMedCentral
37.
go back to reference Patel V, Koo JY. Delusions of parasitosis: suggested dialogue between dermatologist and patient. J Dermatolog Treat. 2015;26(5):456–60.CrossRefPubMed Patel V, Koo JY. Delusions of parasitosis: suggested dialogue between dermatologist and patient. J Dermatolog Treat. 2015;26(5):456–60.CrossRefPubMed
38.
go back to reference Elpern DJ. Cocaine abuse and delusions of parasitosis. Cutis. 1988;42(4):273–4.PubMed Elpern DJ. Cocaine abuse and delusions of parasitosis. Cutis. 1988;42(4):273–4.PubMed
39.
go back to reference Bell DS. The experimental reproduction of amphetamine psychosis. Arch Gen Psychiatry. 1973;29:35–40.CrossRefPubMed Bell DS. The experimental reproduction of amphetamine psychosis. Arch Gen Psychiatry. 1973;29:35–40.CrossRefPubMed
40.
go back to reference Botschev C, Müller N. Opiate receptor antagonists for delusions of parasitosis. Biol Psychiatry. 1991;30(5):530–1.CrossRefPubMed Botschev C, Müller N. Opiate receptor antagonists for delusions of parasitosis. Biol Psychiatry. 1991;30(5):530–1.CrossRefPubMed
41.
go back to reference Vles J, Feron F, Hendriksen J, Jolles J, Van Kroonenburgh M, Weber W. Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit. Neuropediatrics. 2003;34:77–80.CrossRefPubMed Vles J, Feron F, Hendriksen J, Jolles J, Van Kroonenburgh M, Weber W. Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit. Neuropediatrics. 2003;34:77–80.CrossRefPubMed
42.
go back to reference Huber M, Kirchler E, Karner M, et al. Delusional parasitosis and the dopamine transporter. A new insight of etiology? Med Hypotheses. 2007;68:1351–8.CrossRefPubMed Huber M, Kirchler E, Karner M, et al. Delusional parasitosis and the dopamine transporter. A new insight of etiology? Med Hypotheses. 2007;68:1351–8.CrossRefPubMed
43.
go back to reference Gershon ES, Goldstein RE, Moss AJ, et al. Psychosis with ordinary doses of propranolol. Ann Intern Med. 1979;90:938–9.CrossRefPubMed Gershon ES, Goldstein RE, Moss AJ, et al. Psychosis with ordinary doses of propranolol. Ann Intern Med. 1979;90:938–9.CrossRefPubMed
44.
go back to reference Arensberg D, Wenger NK. Psychosis: a probable result of propranolol therapy. Int J Addict. 1979;14(6):785–7.CrossRefPubMed Arensberg D, Wenger NK. Psychosis: a probable result of propranolol therapy. Int J Addict. 1979;14(6):785–7.CrossRefPubMed
45.
go back to reference McGahan DJ, Wojslaw A, Prasad V, Blankenship S. Propranolol-induced psychosis. Ann Pharmacother. 1984;18(7–8):601–3.CrossRef McGahan DJ, Wojslaw A, Prasad V, Blankenship S. Propranolol-induced psychosis. Ann Pharmacother. 1984;18(7–8):601–3.CrossRef
46.
go back to reference Huffman JC, Stern TA. Neuropsychiatric consequences of cardiovascular medications. Dialogues Clin Neurosci. 2007;9(1):29–45.PubMedPubMedCentral Huffman JC, Stern TA. Neuropsychiatric consequences of cardiovascular medications. Dialogues Clin Neurosci. 2007;9(1):29–45.PubMedPubMedCentral
47.
go back to reference Glennon RA, Titeler M, McKenney JD. Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci. 1984;35:2505–11.CrossRefPubMed Glennon RA, Titeler M, McKenney JD. Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci. 1984;35:2505–11.CrossRefPubMed
Metadata
Title
Drug-Induced Tactile Hallucinations Beyond Recreational Drugs
Authors
Mio Nakamura
John Koo
Publication date
01-12-2016
Publisher
Springer International Publishing
Published in
American Journal of Clinical Dermatology / Issue 6/2016
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI
https://doi.org/10.1007/s40257-016-0219-z

Other articles of this Issue 6/2016

American Journal of Clinical Dermatology 6/2016 Go to the issue

Acknowledgement to Referees

Acknowledgement to Referees